ANEEQA NOOR

Dr. ANEEQA NOOR

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 June 2023 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
ZWZuha Waheed
Zuha Waheed
JCJawaria Choudhary
Jawaria Choudhary
FJFaria Hasan Jatala
Faria Hasan Jatala
ANANEEQA NOOR
ANEEQA NOOR
IZInga Zerr
Inga Zerr
SZSaima Zafar
Saima Zafar

Verified
Journal Article
Open access
PDF file
ANANEEQA NOOR
ANEEQA NOOR
SZSaima Zafar
Saima Zafar
Inga ZerrInga Zerr
Inga Zerr
Proteinopathy refers to a group of disorders defined by depositions of amyloids within living tissue. Neurodegenerative proteinopathies, including Alzheimer’s disease, Parkinson’s disease, Creutzfeldt–Jakob disease, and others, constitute a large fraction of these disorders. Amyloids are highly insoluble, ordered, stable, beta-sheet rich proteins. The emerging theory about the pathophysiology of neurodegenerative proteinopathies suggests that the primary amyloid-forming proteins, also known as the prion-like proteins, may exist as multiple proteoforms that contribute differentially towards the disease prognosis. It is therefore necessary to resolve these disorders on the level of proteoforms rather than the proteome. The transient and hydrophobic nature of amyloid-forming proteins and the minor post-translational alterations that lead to the formation of proteoforms require the use of highly sensitive and specialized techniques. Several conventional techniques, like gel electrophoresis and conventional mass spectrometry, have been modified to accommodate the proteoform theory and prion-like proteins. Several new ones, like imaging mass spectrometry, have also emerged. This review aims to discuss the proteoform theory of neurodegenerative disorders along with the utility of these proteomic techniques for the study of highly insoluble proteins and their associated proteoforms.

7 February 2024 in Prion
Verified
Journal Article
Open access
URUrwah Rasheed
Urwah Rasheed
SKSana Khan
Sana Khan
MKMinahil Khalid
Minahil Khalid
ANANEEQA NOOR
ANEEQA NOOR
SZSaima Zafar
Saima Zafar
Creutzfeldt Jakob Disease (CJD) is a rapidly progressive, fatal neurodegenerative disorder, also known as a subacute spongiform encephalopathy. There are three major subtypes of CJD i.e. Sporadic CJD, which occurs for reasons unbeknown to science (85% of known cases), Genetic or Familial CJD which is characterized by the presence of mutations in the human prion protein (PRNP) gene (10-15% cases) and Iatrogenic CJD that occurs via accidental transmission through medical and surgical procedures (1-2% cases). CJD cases occur globally with 1 case per one million population/year. Considerable data is available related to the incidence and prevalence of CJD in Europe and America. However, the global surveillance database is yet to include Asia even though several Asian countries have their own CJD monitoring units. sCJD is the highest among all CJD cases in Asia. China (1957) and Japan (1705) have reported more cases of sCJD than any Asian country and Hong Kong (1) has reported the least. On the other hand, gCJD is highest in Japan (370) and least in India (2). Our analysis establishes the presence of all variants of CJD across Asia. However, in most Asian countries in general and Southeast Asian countries in particular, CJD cases are misdiagnosed and often underreported. Since Asia is the most populated continent in the world, the actual global prevalence of CJD cannot be estimated until and unless these countries are accounted for. Concrete and reliable surveillance networks are needed across Asia to evaluate the prevalence and incidence of CJD in the region. [Figure: see text]The graphical abstract demonstrates the prevalence of CJD cases in the world and systematically analyses the incidence of CJD in Asian countries between the year 1986-2022. Highest number of cases were reported in Japan followed by China. The study emphasizes the need for assimilation of Asian data in global prevalence.

13 September 2025 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
SKShahrukh Khan
Shahrukh Khan
HBHumaira Batool
Humaira Batool
HTHuraira Tariq
Huraira Tariq
ANANEEQA NOOR
ANEEQA NOOR

4 April 2025 in Neuroscience
Verified
Journal Article
Closed access
MMMehwish Mehreen
Mehwish Mehreen
MAMehak Ali
Mehak Ali
HTHuraira Tariq
Huraira Tariq
ANANEEQA NOOR
ANEEQA NOOR
SMsara mumtaz
sara mumtaz
SZSaima Zafar
Saima Zafar

6 September 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
HSHadiqa Shahid
Hadiqa Shahid
TSTehreem Sohail
Tehreem Sohail
ANANEEQA NOOR
ANEEQA NOOR
SZSaima Zafar
Saima Zafar